title: Daclizumab: a novel therapeutic option in severe bullous pemphigoid.
authors.forename: Maja
authors.initials: M
authors.lastname: Mockenhaupt
authors.forename: Martine
authors.initials: M
authors.lastname: Grosber
authors.forename: Johannes
authors.initials: J
authors.lastname: Norganer
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000077561:Daclizumab; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008875:Middle Aged; D010391:Pemphigoid, Bullous / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D000077561:Daclizumab